Chargement de la fiche…
rhumatologie
Dr Pierre Le Blay
Libéral
Montpellier (34080)
Rheumatoid Arthritis Research and Therapies · Autoimmune and Inflammatory Disorders Research · Systemic Lupus Erythematosus Research
0Publications
0Citations
0Lieux d'exercice
Côté patient
Avant votre rendez-vous avec le Dr Pierre Le Blay
Choisissez votre pathologie pour une explication en langage simple.
Parcourir toutes les pathologies →Des applications évaluées par MonRhumato, sélectionnées pour les patients.
MapathoPlateforme communautaire maladies chroniques + annuaire pair-validé
GustaveAgent IA souverain pour information patient sourcée
Remedee LabsBracelet stimulateur d'endorphines pour douleur chroniquePourquoi consulter Dr Pierre Le Blay
- Praticien-chercheur
- Cabinet de groupe — continuité de soins
- Secteur 2 OPTAM — dépassements modérés
- Disponibilité géographique
- Carte Vitale acceptée
- Délais de RDV courts dans la région
Tout est calculé à partir des sources publiques (RPPS, PubMed, OpenAlex, OpenStreetMap…) — aucun classement éditorial.
Parcours
2020
Inserm
2020
Université de Montpellier
2020
Institute for Regenerative Medicine & Biotherapy
2019
Centre Hospitalier Universitaire de Nîmes
2010–2019
Hôpital Lapeyronie
2017
Universidad de Los Andes, Chile
Rayonnement scientifique
0
h-index
0
i10
0
citations
Le h-index mesure la productivité scientifique : ce médecin a publié 9 articles cités au moins 9fois par d'autres chercheurs. Plus c'est élevé, plus son travail influence la communauté médicale.
Tarifs & conventionnement
ConventionnementSecteur 2
OPTAMOPTAM
Carte VitaleOui
apCV (carte Vitale dématérialisée)Non
Dernières publications
Diplômes & qualifications
DES
DES Rhumatologie · Rhumatologie (SM) — Diplôme d'Études Spécialisées
CES
DE Docteur en médecine — Capacité / Certificat d'Études Spéciales
Lieux d'exercice
Domaines d'expertise
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchSystemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies ResearchPsoriasis: Treatment and Pathogenesis
Bibliométrie (OpenAlex)
Profil ↗0
travaux
0
h-index
0
i10-index
0
citations
Rheumatoid Arthritis Research and TherapiesAutoimmune and Inflammatory Disorders ResearchSystemic Lupus Erythematosus ResearchMonoclonal and Polyclonal Antibodies ResearchPsoriasis: Treatment and Pathogenesis
Transversal
42016Rheumatology (Oxford, England)
PubMed ↗Handgrip strength measured by a dynamometer connected to a smartphone: a new applied health technology solution for the self-assessment of rheumatoid arthritis disease activity
2014Joint bone spine
PubMed ↗A severe Whipple disease with an immune reconstitution inflammatory syndrome: an additional case of thalidomide efficiency
2014Joint bone spine
PubMed ↗An atypical sciatica revealing a rhabdomyolysis
2013The Journal of rheumatology
PubMed ↗Acute inflammatory myalgia: think of myositis ossificans circumscripta
Fièvres auto-inflammatoires
22017Arthritis care & research
PubMed ↗Real-World Experience and Impact of Canakinumab in Cryopyrin-Associated Periodic Syndrome: Results From a French Observational Study
2015Arthritis & rheumatology (Hoboken, N.J.)
PubMed ↗Musculoskeletal symptoms in patients with cryopyrin-associated periodic syndromes: a large database study
Anti-TNF
12012The Journal of rheumatology
PubMed ↗Short-term risk of total malignancy and nonmelanoma skin cancers with certolizumab and golimumab in patients with rheumatoid arthritis: metaanalysis of randomized controlled trials
Arthrite juvénile
12017Joint bone spine
PubMed ↗Association of TRAF1-C5 with risk of uveitis in juvenile idiopathic arthritis
Biothérapies non-anti-TNF
12020BMC rheumatology
PubMed ↗Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
Épidémiologie & registres
12017The Journal of rheumatology
PubMed ↗Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD
Essai clinique
12021Rheumatology (Oxford, England)
PubMed ↗A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis
Revue / méta-analyse
12012Clinical and experimental rheumatology
PubMed ↗Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies
Revue générale
12012Clinical and experimental rheumatology
PubMed ↗Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies
Publications HAL
82021Article
A randomized prospective open-label controlled trial comparing the performance of a connected monitoring interface versus physical routine monitoring in patients with rheumatoid arthritis
Rheumatology
2020Article
Successful long-term remission through tapering tocilizumab infusions: a single-center prospective study
BMC Rheumatology
2017Article
Biologic Disease-modifying Antirheumatic Drug (bDMARD)-induced Neutropenia: A Registry from a Retrospective Cohort of Patients with Rheumatic Diseases Treated with 3 Classes of Intravenous bDMARD
Journal of Rheumatology
2017Article
Association of TRAF1-C5 with risk of uveitis in juvenile idiopathic arthritis
Joint Bone Spine
2016Article
Handgrip strength measured by a dynamometer connected to a smartphone: a new applied health technology solution for the self-assessment of rheumatoid arthritis disease activity
Rheumatology
2015Article
Musculoskeletal Symptoms in Patients With Cryopyrin-Associated Periodic Syndromes: A Large Database Study
Arthritis & rheumatology
2012Article
Risk of malignancy including non-melanoma skin cancers with anti-tumor necrosis factor therapy in patients with rheumatoid arthritis: meta-analysis of registries and systematic review of long-term extension studies.
Clinical and experimental rheumatology
2012Article
Short-term Risk of Total Malignancy and Nonmelanoma Skin Cancers with Certolizumab and Golimumab in Patients with Rheumatoid Arthritis: Metaanalysis of Randomized Controlled Trials
Journal of Rheumatology
Rhumatologues à proximité
Données issues de l'Annuaire Santé (ANS) — Licence Ouverte 2.0. Enrichissements à partir de sources publiques. Vous êtes le praticien référencé ? Faites corriger ou retirer votre fiche : demande de rectification ou de retrait.